CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells

International Journal of Molecular Medicine
Qun LiXianbin Chen

Abstract

Stroke is the second most common cause of death worldwide, and thus, it imposes great financial burdens on both individuals and society. Mesenchymal stem cell (MSC) therapy is a promising approach for ischemic brain injury. However, MSC treatment potential is progressively reduced with age, limiting their therapeutic efficacy for brain repair post‑stroke. C1q and tumor necrosis factor‑related protein 9 (CTRP9) is a novel cytoprotective cytokine with antioxidant effects, which is highly expressed in brain tissue. The present study tested the hypothesis that CTRP9 might act as an antisenescence factor to promote the rejuvenation of aged MSCs. MSCs were isolated from the bone marrow of young (8‑weeks‑old) and aged (18‑months‑old) male C57BL/6 mice. Cell proliferation was measured by Cell Counting Kit‑8 assay and cell viability was determined by MTT assay. Gene expression levels of interleukin (IL)‑6 and IL‑10 were evaluated with reverse transcription‑quantitative polymerase chain reaction, and secretion of vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor, and insulin‑like growth factor were measured by ELISA. The expression levels of proteins in the peroxisome proliferator‑activated rece...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jul 5, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·I BadanA Popa-Wagner
Nov 26, 2008·Nature Clinical Practice. Cardiovascular Medicine·Barry J GoldsteinXin L Ma
May 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin D SmithThomas A Buchholz
Feb 11, 2011·Nature·Ergün SahinRonald A DePinho
Nov 4, 2011·Trends in Endocrinology and Metabolism : TEM·Ian S Patten, Zolt Arany
Jan 31, 2012·Trends in Endocrinology and Metabolism : TEM·Jonathan S OakhillBruce E Kemp
Mar 21, 2012·Pediatric Research·Cindy T J van VelthovenCobi J Heijnen
Jun 22, 2012·Annals of Neurology·Cindy T J van VelthovenCobi J Heijnen
Mar 25, 2014·Stem Cells·Borzo GharibiFrancis J Hughes
Jul 10, 2014·The New England Journal of Medicine·Navdeep S Chandel, David A Tuveson
Sep 23, 2014·Blood·Danielle M TownsleyNeal S Young
Feb 24, 2015·Molecular and Cellular Biochemistry·Wenzheng XiaMeng Hou
Mar 12, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T CrepinJ Bamoulid
Apr 14, 2016·Oxidative Medicine and Cellular Longevity·Xinchun YeGuiyun Cui
Jun 15, 2016·Annual Review of Biochemistry·Celine E RieraAndrew Dillin
Jul 7, 2016·Trends in Molecular Medicine·Shailaja Akunuru, Hartmut Geiger
Feb 28, 2017·The Journal of Clinical Investigation·Hanjun LiXizhi Guo
Mar 12, 2017·Journal of Molecular Endocrinology·Guokun YangWensheng Li
Mar 17, 2017·Oxidative Medicine and Cellular Longevity·Dajun ZhaoLifang Yang
Jan 10, 2018·Aging Cell·Joshua GoldbergDavid Schubert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.